Elon Musk reportedly used a range of drugs—including ketamine, ecstasy, and psychedelic mushrooms—while holding a significant advisory role in Donald Trump’s administration, according to sources cited by The New York Times. These individuals claim Musk took ketamine so frequently it resulted in bladder issues, and that he traveled with an estimated daily supply of around 20 pills.
According to anonymous sources familiar with the matter, Musk’s drug use escalated during a period when he donated $275 million to Trump’s presidential campaign and led a key initiative known as the “Department of Government Efficiency,” or DOGE. The Times’ reporting suggests that during this time, Musk regularly used controlled substances, contradicting previous public statements in which he characterized his ketamine use as infrequent.
On Wednesday, Musk announced he was stepping down from his government position, following months of erratic public behavior, including reportedly making a Nazi-like gesture at a rally and insulting cabinet members.
Ecstasy is classified by the U.S. Drug Enforcement Administration (DEA) as a Schedule I substance, with no approved medical use, making it fully prohibited for federal employees. However, Musk held the designation of a “special government employee,” which exempts him from some of the rules that apply to full-time staff.
Ketamine, while legally prescribed in limited circumstances as a Schedule III drug, can violate workplace policies if used recreationally or in combination with other substances. Sources told the Times that Musk developed a dependency on ketamine, using it far more frequently than he admitted publicly. In a March 2024 interview with Don Lemon, Musk had claimed he took only a small amount “about once every two weeks.”
By spring 2023, Musk was reportedly acknowledging to associates that his ketamine use was causing him physical side effects, including bladder problems—a known complication of chronic ketamine use, according to the DEA.
Photographic evidence reviewed by the Times showed a box of medications allegedly belonging to Musk, which included pills marked as Adderall among other unidentified substances.
It is unclear whether Musk was under the influence of any substances while participating in high-level White House meetings or while engaging with foreign leaders, during which he held influence over federal budget decisions.
Asked about the allegations, White House spokesperson Harrison Fields avoided directly addressing whether Musk was subject to drug testing. Instead, Fields praised Musk’s contributions to the administration: “Few CEOs in America would leave the comfort of the C-suite to serve in the federal government. Yet Elon Musk did just that, joining the Trump Administration’s efforts to cut waste, fraud and abuse.”
Fields added that DOGE’s mission “is now embedded in the fabric of the federal government and continues to drive efficiency and save taxpayer dollars.”
Despite SpaceX’s strict drug-free workplace policy—necessary due to its government contracts—insiders claim Musk was given advance notice of random drug tests, potentially undermining their effectiveness.
Public criticism has also emerged from figures who were once close to Musk. In a January newsletter, author and podcaster Sam Harris—who publicly distanced himself from Musk—wrote, “There is something seriously wrong with his moral compass, if not his perception of reality.”
Pump Radar
Stock Alerts